These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25588723)

  • 1. Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.
    Triscott J; Rose Pambid M; Dunn SE
    Stem Cells; 2015 Apr; 33(4):1042-6. PubMed ID: 25588723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
    Triscott J; Lee C; Hu K; Fotovati A; Berns R; Pambid M; Luk M; Kast RE; Kong E; Toyota E; Yip S; Toyota B; Dunn SE
    Oncotarget; 2012 Oct; 3(10):1112-23. PubMed ID: 23047041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
    Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
    Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.
    Zirjacks L; Stransky N; Klumpp L; Prause L; Eckert F; Zips D; Schleicher S; Handgretinger R; Huber SM; Ganser K
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells.
    Liu P; Brown S; Goktug T; Channathodiyil P; Kannappan V; Hugnot JP; Guichet PO; Bian X; Armesilla AL; Darling JL; Wang W
    Br J Cancer; 2012 Oct; 107(9):1488-97. PubMed ID: 23033007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor.
    Liu CC; Wu CL; Lin MX; Sze CI; Gean PW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
    Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
    Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer stem cells for treatment of glioblastoma multiforme.
    Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
    Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram: a novel repurposed drug for cancer therapy.
    Lu C; Li X; Ren Y; Zhang X
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):159-172. PubMed ID: 33426580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.
    Vengoji R; Ponnusamy MP; Rachagani S; Mahapatra S; Batra SK; Shonka N; Macha MA
    Carcinogenesis; 2019 Mar; 40(1):2-14. PubMed ID: 30475990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
    Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
    Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
    Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
    PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
    Hothi P; Martins TJ; Chen L; Deleyrolle L; Yoon JG; Reynolds B; Foltz G
    Oncotarget; 2012 Oct; 3(10):1124-36. PubMed ID: 23165409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.
    Jakola AS; Werlenius K; Mudaisi M; Hylin S; Kinhult S; Bartek J; Salvesen Ø; Carlsen SM; Strandéus M; Lindskog M; Löfgren D; Rydenhag B; Carstam L; Gulati S; Solheim O; Bartek J; Solheim T
    F1000Res; 2018; 7():1797. PubMed ID: 30647912
    [No Abstract]   [Full Text] [Related]  

  • 16. Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review).
    Magrath JW; Kim Y
    Int J Oncol; 2017 Sep; 51(3):753-759. PubMed ID: 28766685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
    Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
    Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumor stem cells as research and treatment targets.
    Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
    Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of cancer stem-like side population in human glioblastoma cells accompanied with stemness gene suppression by Korean herbal recipe MSC500.
    Yao CJ; Han TY; Shih PH; Yi TY; Lai IC; Chang KH; Lai TY; Chang CL; Lai GM
    Integr Cancer Ther; 2014 Nov; 13(6):541-54. PubMed ID: 25359730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.